As part of a multi-year RWE initiative, AMCP Research Institute partnered with IQVIA, payers, pharmaceutical companies, and others to design payer-focused RWE standards that were published in JMCP in September, 2025.
AMCP Summary: 2018 Draft Call Letter
The Centers for Medicare and Medicaid Services (CMS) released 2018 Draft Call Letter on February 1, 2017. Overall, the Draft Call Letter does not contain any major changes that are of serious concern to managed care pharmacy. However, there are several provisions worth noting, such as changes to Star Ratings and efforts to reduce opioid overutilization, that AMCP is seeking feedback on from its members to inform the comments that will be submitted to CMS.
Related
AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
Metabolic diseases drive rising costs and disparities, yet evidence‑based care remains inconsistent. AMCP is advancing guidance, education, and collaboration to support aligned coverage, equitable access, and improved outcomes.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
